Medicared For All Logo

Pamela Weber in Commack, New York

Home New York Commack

Pamela Weber has Ophthalmology as her primary medical specialty. Their primary office is: 283 Commack Rd in Commack, New York. There is an additional office location, for a total of two, for Pamela Weber that can be viewed further down.

They're a part of the: Long Island Vitreo Retinal Consultants Pc medical group which has around 18 members. You can call their office at 631-486-6672 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Columbia University College Of Physicians And Surgeons and graduated in 1984 (around 40 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Pamela A Weber Office Phone and Directions

Pamela Weber
Long Island Vitreo Retinal Consultants Pc
283 Commack Rd
Commack, New York 11725
631-486-6672


Patient Ratings
Please rate your experience with Pamela Weber below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 631-486-6672


Enter a starting address:


Healthcare Info for Pamela Weber

Medical School: Columbia University College Of Physicians And Surgeons
Graduation Year: 1984
The Primary Medical Specialty for Pamela Weber is listed as: Ophthalmology
Approximate Years of Experience: 40
PAC (PECOS ID)#: 1355338385
NPI #: 1235111089
NPI Created On: 11/17/2005
NPI Last Updated Listed as: 05/16/2017
Primary Taxonomy Code: 207W00000X
License Number:
1657721
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Injection of drug into eye
  2. Laser destruction of retinal growth, 1 or more sessions
  3. Laser destruction of retinal growth, 1 or more sessions
  4. Laser destruction of leaking retinal blood vessels, 1 or more sessions
  5. Ultrasound of eye disease, growth, or structure
  6. Eye and medical examination for diagnosis and treatment, established patient
  7. Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
  8. Diagnostic imaging of retina
  9. Extended examination of eye with drawing of retina
  10. Imaging of blood vessels in back of eye using fluorescein dye
  11. Imaging of blood vessels in back of eye using indocyanine-green dye
  12. Photography of the retina
  13. Full field recording of retinal electrical responses to external stimuli with interpretation and report
  14. Photography of content of eyes
  15. New patient office or other outpatient visit, typically 45 minutes
  16. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
  17. Injection, aflibercept, 1 mg
  18. Injection, brolucizumab-dbll, 1 mg
  19. Injection, ranibizumab, 0.1 mg
  20. Injection, bevacizumab, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792980817

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DRY EYE

Name of Drug #1: RESTASIS MULTIDOSE

Open Associated Drug #1: 0023-5301-05


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792980819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DRY EYE

Name of Drug #1: RESTASIS MULTIDOSE

Open Associated Drug #1: 0023-5301-05


Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792980821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DRY EYE

Name of Drug #1: RESTASIS MULTIDOSE

Open Associated Drug #1: 0023-5301-05


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792980823

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DRY EYE

Name of Drug #1: RESTASIS MULTIDOSE

Open Associated Drug #1: 0023-5301-05


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835960169

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835960163

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology and Ophthalmology

Name of Drug #1: SUSVIMO

Open Associated Drug #1: 50242-078-12


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835960167

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835960173

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835960175

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $3,075

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 813354367

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: BEOVU

Open Associated Drug #1: 0078-0827-99


Additional Office Locations

1. Long Island Vitreo Retinal Consultants Pc
1500 William Floyd Pkwy
Shirley, NY 11967
Suite 304
Group Members: 18

Phone: 631-486-6672

Enter a starting address:


Ophthalmology Professionals in Commack

6080 Jericho Tpke
Commack, NY

Providers in Long Island Vitreo Retinal Consultants Pc

1.Steven Bodine Md

915 Palmer Rd
Bronxville Ny 10708-3304
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

2.Steven Bodine Md

17 Squadron Blvd
New City Ny 10956-5271
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

3.Vincent Deramo Md

600 Northern Blvd
Great Neck Ny 11021-5200
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

4.Vincent Deramo Md

200 Motor Pkwy
Hauppauge Ny 11788-5100
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

5.David Fastenberg Md

600 Northern Blvd
Great Neck Ny 11021-5200
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

6.David Fastenberg Md

200 Motor Pkwy
Hauppauge Ny 11788-5100
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

View all 18 members of Long Island Vitreo Retinal Consultants Pc medical group